Seven Mile Advisory’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,426
Closed -$210K 182
2026
Q1
$210K Sell
2,426
-1,223
-34% -$117K 0.15% 159
2025
Q4
$351K Sell
3,649
-1,108
-23% -$108K 0.06% 147
2025
Q3
$453K Buy
4,757
+2,190
+85% +$201K 0.07% 142
2025
Q2
$224K Sell
2,567
-169
-6% -$14.3K 0.13% 154
2025
Q1
$246K Buy
2,736
+145
+6% +$13K 0.16% 136
2024
Q4
$207K Buy
2,591
+333
+15% +$28.8K 0.13% 152
2024
Q3
$203K Buy
+2,258
New +$190K 0.13% 156
2024
Q2
Sell
-2,493
Closed -$217K 166
2024
Q1
$217K Buy
+2,493
New +$213K 0.16% 136

Other funds holding MDT

Seven Mile Advisory's MDT Position: Q2 2026 in Review

Seven Mile Advisory sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,426 shares — an estimated $210K sold.

Seven Mile Advisory first reported a position in MDT in Q1 2024 and held it in 8 quarters. The position peaked at $453K in Q3 2025. 2,138 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Seven Mile Advisory reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Seven Mile Advisory sold 2,426 Medtronic shares in Q2 2026, an estimated $210K.
  • Seven Mile Advisory first reported a position in Medtronic in Q1 2024 and held it in 8 quarters.
  • Seven Mile Advisory's Medtronic position peaked at $453K in Q3 2025.
  • 2,138 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Seven Mile Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.